DUBLIN – European biotechnology continued its strong post-summer momentum, with two private equity deals disclosed Tuesday, a €36.6 million (US$41 million) series C round at Spanish firm Laboratoris Sanifit S.L. and a $21 million series A round at London-based Reviral Ltd.